Clinical Trial Update: Simvastatin in Relapsing Remitting Multiple Sclerosis (RRMS) Patients Using Avonex Compared to Placebo [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating simvastatin in relapsing-remitting multiple sclerosis patients treated with Avonex vs placebo has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• Avonex (Interferon beta-1a)
• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Relapsing Remitting Multiple Sclerosis | Phase 3 | Status: COMPLETED